Patents

US 10441661 B2: Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof

Granted
2019-10-15
Filed
2019-03-01 application 16290496
Type
Utility · 14 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The presently described technology provides compositions comprising aryl carboxylic acids chemically conjugated to hydromorphone (4,5-α-epoxy-3-hydroxy-17-methyl morphinan-6-one) to form novel prodrugs/compositions of hydromorphone. The hydromorphone prodrugs of the present technology have decreased side effects and decreased potential for abuse compared to unconjugated hydromorphone. The present technology also provides methods of treating patients, pharmaceutical kits and methods of synthesizing conjugates of the present technology.

Source: PVGPATDIS, file of 2026-04-10 (ipg191015.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
KEMPHARM, INC. 57 patentsUS company or organizationFour Corners, FLKEMPHARM, INC Form D issuer EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Travis MickleKissimmee, FL83PVGPATDIS, file of 2026-04-10
Sven GuentherCoralville, IA63PVGPATDIS, file of 2026-04-10
Guochen ChiCoralville, IA41PVGPATDIS, file of 2026-04-10
Jaroslaw KanskiBlacksburg, VA30PVGPATDIS, file of 2026-04-10
Andrea K. MartinFincastle, VA30PVGPATDIS, file of 2026-04-10
Bindu BeraBlacksburg, VA29PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K47/55PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P11/14PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2026-03-13Release of security interest
Release of security interest
ALTER DOMUS (US) LLC signed 2026-03-12ZEVRA THERAPEUTICS, INC. CELEBRATION, FL75080/907PASDL, file of 2026-10-15
2024-04-08Security interest Security interest
Security interest
ZEVRA THERAPEUTICS, INC. signed 2024-04-05ALTER DOMUS (US) LLC CHICAGO, IL67040/637PASDL, file of 2026-10-15
2024-02-23Name change
Change of name
KEMPHARM, INC. signed 2023-02-21ZEVRA THERAPEUTICS, INC. CELEBRATION, FL66664/108PASDL, file of 2026-10-15
2019-05-22Assignment
Assignment of assignor's interest
GUENTHER, SVEN signed 2017-09-19
MICKLE, TRAVIS signed 2017-09-19
BERA, BINDU signed 2017-09-20
KANSKI, JAROSLAW signed 2017-09-20
MARTIN, ANDREA K. signed 2017-09-20
CHI, GUOCHEN signed 2017-09-21
KEMPHARM, INC. CELEBRATION, FL49257/696ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.